Home / Companies / News / Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla's Gulf arm to sell 4 biosimilar medicines in Australia, New Zealand

Cipla stock went up by almost 3 per cent on Tuesday

Premium

1 min read Last Updated : Mar 03 2021 | 4:03 AM IST

Mumbai-based drug major Cipla said its Gulf subsidiary is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand that had an aggregate sales of $700 mn in 2020 in Australia.

Cipla stock went up by almost 3 per cent on Tuesday.

Topics : Cipla biosimilar drugs Pharma Companies biosimilars

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in